Showing 1–7 of 7 results for author: Yates, J

An Asymptotic Analysis of Bivalent Monoclonal Antibody-Antigen Binding

Authors: Luke A Heirene, Helen M Byrne, James W T Yates, Eamonn A Gaffney

Abstract: Ligand-receptor interactions are fundamental to many biological processes. For example in antibody-based immunotherapies, the dynamics of an antibody binding with its target antigen directly influence the potency and efficacy of monoclonal antibody (mAb) therapies. In this paper, we present an asymptotic analysis of an ordinary differential equation (ODE) model of bivalent antibody-antigen binding… ▽ More Ligand-receptor interactions are fundamental to many biological processes. For example in antibody-based immunotherapies, the dynamics of an antibody binding with its target antigen directly influence the potency and efficacy of monoclonal antibody (mAb) therapies. In this paper, we present an asymptotic analysis of an ordinary differential equation (ODE) model of bivalent antibody-antigen binding in the context of mAb cancer therapies, highlighting the added complexity associated with bivalency of the antibody. To understand what drives the complex temporal dynamics of bivalent antibody-antigen binding, we construct asymptotic approximations to the model's solutions at different timescales and antibody concentrations that are in good agreement with numerical simulations of the full model. We show how the dynamics differ between two scenarios; a region where unbound antigens are abundant, and one where the number of unbound antigens is small such that the dominant balance within the model equations changes. Of particular importance to the potency and efficacy of mAb treatments are the values of quantities such as antigen occupancy and bound antibody number. We use the results of our asymptotic analysis to approximate the long-time values of these quantities that could be combined with experimental data to facilitate parameter estimation. △ Less

Submitted 16 January, 2025; originally announced January 2025.

Brain-like variational inference

Authors: Hadi Vafaii, Dekel Galor, Jacob L. Yates

Abstract: Inference in both brains and machines can be formalized by optimizing a shared objective: maximizing the evidence lower bound (ELBO) in machine learning, or minimizing variational free energy (F) in neuroscience (ELBO = -F). While this equivalence suggests a unifying framework, it leaves open how inference is implemented in neural systems. Here, we show that online natural gradient descent on F, u… ▽ More Inference in both brains and machines can be formalized by optimizing a shared objective: maximizing the evidence lower bound (ELBO) in machine learning, or minimizing variational free energy (F) in neuroscience (ELBO = -F). While this equivalence suggests a unifying framework, it leaves open how inference is implemented in neural systems. Here, we show that online natural gradient descent on F, under Poisson assumptions, leads to a recurrent spiking neural network that performs variational inference via membrane potential dynamics. The resulting model -- the iterative Poisson variational autoencoder (iP-VAE) -- replaces the encoder network with local updates derived from natural gradient descent on F. Theoretically, iP-VAE yields a number of desirable features such as emergent normalization via lateral competition, and hardware-efficient integer spike count representations. Empirically, iP-VAE outperforms both standard VAEs and Gaussian-based predictive coding models in sparsity, reconstruction, and biological plausibility. iP-VAE also exhibits strong generalization to out-of-distribution inputs, exceeding hybrid iterative-amortized VAEs. These results demonstrate how deriving inference algorithms from first principles can yield concrete architectures that are simultaneously biologically plausible and empirically effective. △ Less

Submitted 16 May, 2025; v1 submitted 25 October, 2024; originally announced October 2024.

Histopathological Image Classification with Cell Morphology Aware Deep Neural Networks

Authors: Andrey Ignatov, Josephine Yates, Valentina Boeva

Abstract: Histopathological images are widely used for the analysis of diseased (tumor) tissues and patient treatment selection. While the majority of microscopy image processing was previously done manually by pathologists, recent advances in computer vision allow for accurate recognition of lesion regions with deep learning-based solutions. Such models, however, usually require extensive annotated dataset… ▽ More Histopathological images are widely used for the analysis of diseased (tumor) tissues and patient treatment selection. While the majority of microscopy image processing was previously done manually by pathologists, recent advances in computer vision allow for accurate recognition of lesion regions with deep learning-based solutions. Such models, however, usually require extensive annotated datasets for training, which is often not the case in the considered task, where the number of available patient data samples is very limited. To deal with this problem, we propose a novel DeepCMorph model pre-trained to learn cell morphology and identify a large number of different cancer types. The model consists of two modules: the first one performs cell nuclei segmentation and annotates each cell type, and is trained on a combination of 8 publicly available datasets to ensure its high generalizability and robustness. The second module combines the obtained segmentation map with the original microscopy image and is trained for the downstream task. We pre-trained this module on the Pan-Cancer TCGA dataset consisting of over 270K tissue patches extracted from 8736 diagnostic slides from 7175 patients. The proposed solution achieved a new state-of-the-art performance on the dataset under consideration, detecting 32 cancer types with over 82% accuracy and outperforming all previously proposed solutions by more than 4%. We demonstrate that the resulting pre-trained model can be easily fine-tuned on smaller microscopy datasets, yielding superior results compared to the current top solutions and models initialized with ImageNet weights. The codes and pre-trained models presented in this paper are available at: https://github.com/aiff22/DeepCMorph △ Less

Submitted 11 July, 2024; originally announced July 2024.

Poisson Variational Autoencoder

Authors: Hadi Vafaii, Dekel Galor, Jacob L. Yates

Abstract: Variational autoencoders (VAEs) employ Bayesian inference to interpret sensory inputs, mirroring processes that occur in primate vision across both ventral (Higgins et al., 2021) and dorsal (Vafaii et al., 2023) pathways. Despite their success, traditional VAEs rely on continuous latent variables, which deviates sharply from the discrete nature of biological neurons. Here, we developed the Poisson… ▽ More Variational autoencoders (VAEs) employ Bayesian inference to interpret sensory inputs, mirroring processes that occur in primate vision across both ventral (Higgins et al., 2021) and dorsal (Vafaii et al., 2023) pathways. Despite their success, traditional VAEs rely on continuous latent variables, which deviates sharply from the discrete nature of biological neurons. Here, we developed the Poisson VAE (P-VAE), a novel architecture that combines principles of predictive coding with a VAE that encodes inputs into discrete spike counts. Combining Poisson-distributed latent variables with predictive coding introduces a metabolic cost term in the model loss function, suggesting a relationship with sparse coding which we verify empirically. Additionally, we analyze the geometry of learned representations, contrasting the P-VAE to alternative VAE models. We find that the P-VAE encodes its inputs in relatively higher dimensions, facilitating linear separability of categories in a downstream classification task with a much better (5x) sample efficiency. Our work provides an interpretable computational framework to study brain-like sensory processing and paves the way for a deeper understanding of perception as an inferential process. △ Less

Submitted 8 December, 2024; v1 submitted 23 May, 2024; originally announced May 2024.

Comments: Published as a NeurIPS 2024 Spotlight paper (https://openreview.net/forum?id=ektPEcqGLb)

How to optimize neuroscience data utilization and experiment design for advancing brain models of visual and linguistic cognition?

Authors: Greta Tuckute, Dawn Finzi, Eshed Margalit, Joel Zylberberg, SueYeon Chung, Alona Fyshe, Evelina Fedorenko, Nikolaus Kriegeskorte, Jacob Yates, Kalanit Grill-Spector, Kohitij Kar

Abstract: In recent years, neuroscience has made significant progress in building large-scale artificial neural network (ANN) models of brain activity and behavior. However, there is no consensus on the most efficient ways to collect data and design experiments to develop the next generation of models. This article explores the controversial opinions that have emerged on this topic in the domain of vision a… ▽ More In recent years, neuroscience has made significant progress in building large-scale artificial neural network (ANN) models of brain activity and behavior. However, there is no consensus on the most efficient ways to collect data and design experiments to develop the next generation of models. This article explores the controversial opinions that have emerged on this topic in the domain of vision and language. Specifically, we address two critical points. First, we weigh the pros and cons of using qualitative insights from empirical results versus raw experimental data to train models. Second, we consider model-free (intuition-based) versus model-based approaches for data collection, specifically experimental design and stimulus selection, for optimal model development. Finally, we consider the challenges of developing a synergistic approach to experimental design and model building, including encouraging data and model sharing and the implications of iterative additions to existing models. The goal of the paper is to discuss decision points and propose directions for both experimenters and model developers in the quest to understand the brain. △ Less

Submitted 28 December, 2024; v1 submitted 6 January, 2024; originally announced January 2024.

Initial recommendations for performing, benchmarking, and reporting single-cell proteomics experiments

Authors: Laurent Gatto, Ruedi Aebersold, Juergen Cox, Vadim Demichev, Jason Derks, Edward Emmott, Alexander M. Franks, Alexander R. Ivanov, Ryan T. Kelly, Luke Khoury, Andrew Leduc, Michael J. MacCoss, Peter Nemes, David H. Perlman, Aleksandra A. Petelski, Christopher M. Rose, Erwin M. Schoof, Jennifer Van Eyk, Christophe Vanderaa, John R. Yates III, Nikolai Slavov

Abstract: Analyzing proteins from single cells by tandem mass spectrometry (MS) has become technically feasible. While such analysis has the potential to accurately quantify thousands of proteins across thousands of single cells, the accuracy and reproducibility of the results may be undermined by numerous factors affecting experimental design, sample preparation, data acquisition, and data analysis. Broadl… ▽ More Analyzing proteins from single cells by tandem mass spectrometry (MS) has become technically feasible. While such analysis has the potential to accurately quantify thousands of proteins across thousands of single cells, the accuracy and reproducibility of the results may be undermined by numerous factors affecting experimental design, sample preparation, data acquisition, and data analysis. Broadly accepted community guidelines and standardized metrics will enhance rigor, data quality, and alignment between laboratories. Here we propose best practices, quality controls, and data reporting recommendations to assist in the broad adoption of reliable quantitative workflows for single-cell proteomics. △ Less

Submitted 12 September, 2022; v1 submitted 19 July, 2022; originally announced July 2022.

Comments: Supporting website: https://single-cell.net/guidelines

Journal ref: Nature Methods, 20, 375--386 (2023)

Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions

Authors: Ana Osojnik, Eamonn A. Gaffney, Michael Davies, James W. T. Yates, Helen M. Byrne

Abstract: We study a five-compartment mathematical model originally proposed by Kuznetsov et al. (1994) to investigate the effect of nonlinear interactions between tumour and immune cells in the tumour microenvironment, whereby immune cells may induce tumour cell death, and tumour cells may inactivate immune cells. Exploiting a separation of timescales in the model, we use the method of matched asymptotics… ▽ More We study a five-compartment mathematical model originally proposed by Kuznetsov et al. (1994) to investigate the effect of nonlinear interactions between tumour and immune cells in the tumour microenvironment, whereby immune cells may induce tumour cell death, and tumour cells may inactivate immune cells. Exploiting a separation of timescales in the model, we use the method of matched asymptotics to derive a new two-dimensional, long-timescale, approximation of the full model, which differs from the quasi-steady-state approximation introduced by Kuznetsov et al. (1994), but is validated against numerical solutions of the full model. Through a phase-plane analysis, we show that our reduced model is excitable, a feature not traditionally associated with tumour-immune dynamics. Through a systematic parameter sensitivity analysis, we demonstrate that excitability generates complex bifurcating dynamics in the model. These are consistent with a variety of clinically observed phenomena, and suggest that excitability may underpin tumour-immune interactions. The model exhibits the three stages of immunoediting - elimination, equilibrium, and escape, via stable steady states with different tumour cell concentrations. Such heterogeneity in tumour cell numbers can stem from variability in initial conditions and/or model parameters that control the properties of the immune system and its response to the tumour. We identify different biophysical parameter targets that could be manipulated with immunotherapy in order to control tumour size, and we find that preferred strategies may differ between patients depending on the strength of their immune systems, as determined by patient-specific values of associated model parameters. △ Less

Submitted 3 September, 2019; originally announced September 2019.

Comments: 29 pages, 15 figures